Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ADA 2026 5 - 8 June 2026

HbA1c and Weight Outcomes for Individuals With T2D Persistent on Oral Semaglutide 25 mg: A PIONEER PLUS Post Hoc Analysis

Authors :

Yesha Patel^1,2; Josh Noone²; Chethana K. Ramesh³; Chalak Muhammad²

Affiliations

View Details Hide Details

Download .PDF

Keywords

Diabetes

Congress poster

GLP-1 RA

Semaglutide (oral)

PHASE 3 (RCT)